The Assar Gabrielssons Foundation annually awards two grants of SEK 600,000 each for major research projects. The funds can be used for salary costs (incl. own salary) and operating costs, and may be used for up to three years. Applications from the University of Gothenburg and Region Västra Götaland are preferred. Eligible to apply are postdocs and young researchers 2-7 years after their defense. Decutible time can be applied for…
Melanoma thickness equally hard for algorithms and dermatologists to judge
NEW STUDY. Assessing the thickness of melanoma is difficult, whether done by an experienced dermatologist or a well-trained machine-learning algorithm. A study from the University of Gothenburg shows that the algorithm and the dermatologists had an equal success rate in interpreting dermoscopic images. In diagnosing melanoma, dermatologists evaluate whether it is an aggressive form (invasive melanoma), where the cancer cells grow down into the dermis and there is a risk…
Sahlgrenska Cancer Center at SU impressed during site visit
COOPERATION. Recently, an important step was taken on the Sahlgrenska Cancer Center’s path towards being accredited as a Comprehensive Cancer Center. The organization that decides on the accreditation, OECI, made a physical site visit on 23 February, where the auditors stated that SCC had come a long way. The establishment of the Sahlgrenska Cancer Center (SCC) at Sahlgrenska University Hospital has been ongoing since 2020. The SCC strengthens the collaboration…
Eight researchers at Sahlgrenska Academy receive funding from the Lundberg Foundation
GRANTS. Of the SEK 37 million that has just been awarded by the IngaBritt and Arne Lundberg Research Foundation, most goes to researchers from the University of Gothenburg. Professor Eva Forssell-Aronsson has been given the biggest grant. She can now buy a combined magnetic resonance scanner and positron camera for conducting research on radioactive pharmaceuticals to treat metastatic cancer. Eva Forssell-Aronsson, a medical physicist and professor of medical radiation physics,…
Increased survival with eye melanoma in clinical trial
NEW STUDY. Once it has spread (metastasized), uveal (intraocular or eye) melanoma — an unusual form of cancer — has a very high mortality rate. In a study published in Nature Communications, researchers and doctors at the University of Gothenburg and Sahlgrenska University Hospital show that, in a small group of patients with metastatic uveal melanoma, a new combination treatment can bring about tumor shrinkage and prolonged survival. Uveal melanoma,…